In recent years, the biopharmaceutical industry has increasingly focused on rare diseases as an important area for research. While rare diseases are clearly a commercially attractive area, the business model for rare / orphan products can be very different to the ‘mass market’ pharma business model.
TCP Group has developed expertise in providing logistical and patient support solutions for orphan / rare disease products. Our team of highly trained staff has successfully managed the dispensing, distribution and homecare support for many highly specialist products in the Irish market.
Our data driven solutions are designed to greatly enhance the visibility, security, and control of your specialty product supply chain. Some of the therapeutic areas where we operate include:
Talk to us today about how we can support your rare disease products in the Irish marketplace.